Ryan Preblick sold $1.4M of INDV stock

Ryan Preblick, Chief Financial Officer of Indivior Pharmaceuticals, Inc. (INDV), sold 36,000 shares of INDV stock worth $1.4M, per an SEC Form 4 filed Jun 10, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 8, 2026, 2 days before it was made public.

INDV has moved -3.0% since the trade date, from $37.39 to $36.28 (Nov 2, 2026 close).